CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,534,640 | -64.2% | 164,440 | -62.2% | 6.90% | +162.2% |
| Q3 2022 | $21,054,000 | +10.4% | 434,560 | -10.5% | 2.63% | +37.4% |
| Q2 2022 | $19,079,000 | -54.3% | 485,600 | -57.2% | 1.92% | -31.2% |
| Q1 2022 | $41,783,000 | +874.0% | 1,135,110 | +1106.0% | 2.79% | +1096.1% |
| Q4 2021 | $4,290,000 | -72.4% | 94,120 | -78.3% | 0.23% | -65.2% |
| Q3 2021 | $15,529,000 | +4.7% | 434,500 | -42.0% | 0.67% | +13.0% |
| Q2 2021 | $14,829,000 | +37.8% | 749,310 | +62.0% | 0.59% | +55.6% |
| Q1 2021 | $10,758,000 | – | 462,500 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |